Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blood pressure circadian rhythm and standard antihypertensive therapy in type 2 diabetes with hypertension
ChiCTR-IPR-16007955Phase 4Completed
- Sponsor
- Southwest Health System
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of irbesartan in type 2 diabetes mellitus (T2DM) and hypertension (HTN) (4 arms), sponsored by Southwest Health System. Primary endpoints: Ambulatory blood pressure monitoring, Intima-media thickness and 1 more. Started Jan 2015; status: completed.
02
Drugs
irbesartan
03
Conditions
type 2 diabetes mellitus (T2DM)hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR-IPR-16007955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16007955.